We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
MLNOV.PA

Price
10.50
Stock movement up
+- (%)
Company name
Novatech Industries SA
Exchange
(PA
,
Currency
EUR
)
Sector
Technology >
Electronic Components
Market cap
19.80M
Ent value
-
Price/Sales
-
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
23.00%
1 year return
130.59%
3 year return
39.31%
5 year return
0.78%
10 year return
-
Last updated: 2025-09-17

DIVIDENDS

MLNOV.PA does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book-
EV to Sales-

FINANCIALS

Per share

Loading...
Per share data
Current share count1.01M
EPS (TTM)-
FCF per share (TTM)-

Income statement

Loading...
Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
CashNaNB
Net receivablesNaNB
Total current assetsNaNB
GoodwillNaNB
Intangible assetsNaNB
Property, plant and equipmentNaNB
Total assetsNaNB
Accounts payableNaNB
Short/Current long term debtNaNB
Total current liabilitiesNaNB
Total liabilitiesNaNB
Shareholder's equityNaNB
Net tangible assetsNaNB

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open19.60
Daily high19.60
Daily low19.60
Daily Volume0K
All-time high20.40
1y analyst estimate-
Beta0.65
EPS (TTM)-
Dividend per share-
Ex-div date25 May 2010
Next earnings date-

Downside potential

Loading...
Downside potential data
MLNOV.PAS&P500
Current price drop from All-time high-3.92%-1.06%
Highest price drop-95.10%-56.47%
Date of highest drop25 Feb 20149 Mar 2009
Avg drop from high-37.12%-10.99%
Avg time to new high27 days12 days
Max time to new high1168 days1805 days
COMPANY DETAILS
MLNOV.PA (Novatech Industries SA) company logo
Marketcap
19.80M
Marketcap category
Small-cap
Description
Novatech Industries engages in the research and development of electronic and mechanical design works in Europe. The company also manufactures box build products; and medical, power, geolocation, and household goods. Novatech Industries was incorporated in 1998 and is based in Lannion, France.
Employees
298
Investor relations
-
CEO
Country
France
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Thinking about what to do with your GL Events shares? Whether you are sizing up an entry point or reassessing your position after a strong rally, now is a great time to take stock of what is really ha...
September 9, 2025
The cider brand has added a high-contrast NaviLens QR code to its cans.
September 9, 2025
BioReference health, JPMorgan Chase and an Italian fashion retailer are making the job cuts amid market uncertainty
September 9, 2025
Temenos also the winner for Bank Deposit Transformation with Credem and listed in the 2025 IDC FinTech Rankings Top 25GRAND-LANCY, Switzerland, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Temenos (SIX: TEMN), ...
September 9, 2025
The Management Board of Artea Bankas has approved changes to the management and organizational structure. The Management Board has received a notice from board member Mindaugas Rudys regarding his res...
September 9, 2025
Novartis agreed to buy Tourmaline Bio in a roughly $1.4 billion-dollar deal that boosts its cardiovascular drug pipeline with access to the targeted therapy drug pacibekitug. The Swiss pharmaceuti...
September 9, 2025
Novartis will acquire Tourmaline Bio for $48 per share, valuing the New York-based biopharmaceutical company at $1.4 billion on a fully diluted basis, the Swiss pharma giant said on Tuesday. Tourmali...
September 9, 2025